Solen Therapeutics Files Annual Proxy Statement
Ticker: SLNO · Form: DEF 14A · Filed: Apr 22, 2025 · CIK: 1484565
| Field | Detail |
|---|---|
| Company | Soleno Therapeutics Inc (SLNO) |
| Form Type | DEF 14A |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, executive-compensation, corporate-governance
Related Tickers: SLNO
TL;DR
Solen Therapeutics (SLNO) filed its proxy statement, detailing exec pay and governance for the 2024 fiscal year.
AI Summary
Solen Therapeutics Inc. filed its DEF 14A on April 22, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and other corporate governance matters. The company, formerly known as Capnia, Inc., is based in Redwood City, CA.
Why It Matters
This filing provides shareholders with crucial information regarding executive compensation, director elections, and other important corporate governance proposals, enabling informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine annual filing (DEF 14A) that discloses corporate governance and executive compensation information, not a filing that typically indicates immediate financial risk.
Key Numbers
- 2024 — Fiscal Year End (Reporting period for the proxy statement)
- 20250422 — Filing Date (Date the DEF 14A was submitted to the SEC)
Key Players & Entities
- SOLENO THERAPEUTICS INC (company) — Filer
- Capnia, Inc. (company) — Former Company Name
- Redwood City, CA (location) — Business Address
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Proxy Statement, is used to solicit shareholder votes on important corporate matters, such as the election of directors and executive compensation.
When is the fiscal year end for Soleno Therapeutics Inc. that this filing pertains to?
The filing pertains to the fiscal year ending December 31, 2024.
What was Soleno Therapeutics Inc. formerly known as?
Soleno Therapeutics Inc. was formerly known as Capnia, Inc.
Where is Soleno Therapeutics Inc. located?
The company's business address is 100 Marine Parkway, Suite 400, Redwood City, CA 94065.
What is the SEC file number for Soleno Therapeutics Inc.?
The SEC file number for Soleno Therapeutics Inc. is 001-36593.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 22, 2025 regarding SOLENO THERAPEUTICS INC (SLNO).